07/24/2025
3:30 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:31 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:31 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form DEF 14A | |
05/09/2025
7:42 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/03/2025
4:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
6:11 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
4:49 PM | Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/09/2024
7:21 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/08/2024
3:30 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
7:00 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
